LumenAstra develops a device utilizing patented radiometry for non-invasive, real-time measurement of internal brain temperature several centimeters below the surface. This capability provides clinicians with accurate thermal data to optimize neuroprotection during procedures like aortic arch surgery. The technology also supports applications in military heat stress monitoring and consumer athletic performance optimization.
Funding
$256K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Accurate measurement of core body temperature is critical for managing conditions like cancer hyperthermia therapy and traumatic brain injury, but current methods are often invasive or lack real-time monitoring capabilities. Existing solutions may not be suitable for continuous, non-invasive monitoring in ambulatory or remote settings.
Solution
LumenAstra has developed a wearable, non-invasive deep-tissue temperature sensor that accurately measures internal body temperature using radio frequency (RF) technology. The sensor measures temperature deep below the skin, enabling continuous monitoring of temperature variations. This technology allows for real-time insights into internal body temperature, addressing the limitations of traditional methods.
Target Audience
The primary target audience includes healthcare providers and researchers involved in cancer hyperthermia therapy, brain injury management, and other applications requiring precise core body temperature monitoring.
Features
- Non-invasive measurement of internal body temperatures
- Wearable form factor for continuous monitoring
- Utilizes radio frequency (RF) technology to measure deep-tissue temperature
- Technology based on a patent developed in collaboration with the University of Colorado Radio Frequency Lab
- Miniaturized probe electronics, reduced to a single 2mm chip